Medicinal Cannabis Guidance and Resources for Health Professionals to Inform Clinical Decision Making

- Graham, Myfanwy, Renaud, Elianne, Lucas, Catherine J., Schneider, Jennifer, Martin, Jennifer H.

Cannabidiol drug interaction considerations for prescribers and pharmacists

- Graham, Myfanwy, Martin, Jennifer H., Lucas, Catherine J., Murnion, Bridin, Schneider, Jennifer

NSW Cannabis Medicines Advisory Service preliminary survey results: enquirer perceptions and patient outcomes

- Graham, Myfanwy, Bird, Sonia, Howard, Zachary, Dobson, Michelle, Palazzi, Kerrin, Lucas, Catherine J., Schneider, Jennifer, Eagar, Kathy, Martin, Jennifer H.

Vancomycin therapeutic drug monitoring in paediatrics

- Patel, Joanne, Lucas, Catherine J., Ryan, Jessica, Jenkins, Michelle, Martin, Jennifer H.

Optimising low-dose methotrexate for rheumatoid arthritis—a review

- Lucas, Catherine J., Dimmitt, Simon B., Martin, Jennifer H.

Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects.

- Dryburgh, Laura M., Bolan, Nanthi S., Grof, Christopher P. L., Galettis, Peter, Schneider, Jennifer, Lucas, Catherine J., Martin, Jennifer H.

Exogenous cannabinoid efficacy: merely a pharmacokinetic interaction?

- Martin, Jennifer H., Schneider, Jennifer, Lucas, Catherine J., Galettis, Peter

Laxative use in inpatients on oxycodone/naloxone prolonged release and oxycodone prolonged release for cancer and non-cancer pain

- Patel, Joanne, Lucas, Catherine J., Margalit, Maxwell, Martin, Jennifer H.

The pharmacokinetics and the pharmacodynamics of cannabinoids

- Lucas, Catherine J., Galettis, Peter, Schneider, Jennifer

Pharmacokinetic-guided dosing of new oral cancer agents

- Lucas, Catherine J., Martin, Jennifer H.

Predicting drug interactions in addiction treatment

- Lucas, Catherine J., Patel, Joanne, Martin, Jennifer H.